Literature DB >> 14511927

Anatomical loci of HIV-associated immune activation and association with viraemia.

Sujatha Iyengar1, Bennett Chin, Joseph B Margolick, Beulah P Sabundayo, David H Schwartz.   

Abstract

BACKGROUND: Lymphocyte activation, associated with vaccination or infection, can be measured by positron emission tomography (PET). We investigated the ability of PET to detect and measure magnitude of lymph-node activation among asymptomatic HIV-1-infected individuals.
METHODS: Initially we assessed PET response in eight HIV-1-uninfected individuals who had received licensed killed influenza vaccine. In an urban teaching hospital, we recruited 12 patients recently infected with HIV-1 (<18 months since seroconversion) and 11 chronic long-term HIV-1 patients who had stable viraemia by RT-PCR (non-progressors). After injection with fluorine-18-labelled fluorodeoxyglucose, patients underwent PET. We correlated summed PET signal from nodes with viral load by linear regression on log-transformed values.
FINDINGS: Node activation was more localised after vaccination than after HIV-1 infection. In early and chronic HIV-1 disease, node activation was greater in cervical and axillary than in inguinal and iliac chains (p<0.0001), and summed PET signal correlated with viraemia across a 4 log range (r2=0.98, p<0.0001). Non-progressors had small numbers of persistently active nodes, most of which were surgically accessible.
INTERPRETATION: The anatomical restriction we noted may reflect microenvironmental niche selection, and tight correlation of PET signal with viraemia suggests target-cell activation determines steady-state viral replication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511927     DOI: 10.1016/S0140-6736(03)14363-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Chronic HIV-1 infection mimicking splenic malignant lymphoma on F-18 FDG-PET/CT.

Authors:  Florent Valour; Agathe Sénéchal; Christian Chidiac; Tristan Ferry
Journal:  BMJ Case Rep       Date:  2012-01-18

2.  (18)F-FDG uptake at vaccination site.

Authors:  Niall Sheehy; Laura Drubach
Journal:  Pediatr Radiol       Date:  2007-12-13

3.  Visualization of a primary anti-tumor immune response by positron emission tomography.

Authors:  Chengyi J Shu; Shuling Guo; Young J Kim; Stephanie M Shelly; Amar Nijagal; Pritha Ray; Sanjiv S Gambhir; Caius G Radu; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

4.  FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1).

Authors:  Emmanouil Panagiotidis; Demetrios Exarhos; Irene Housianakou; Apostolos Bournazos; Ioannis Datseris
Journal:  Eur Radiol       Date:  2010-02-26       Impact factor: 5.315

5.  18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.

Authors:  Mark N Polizzotto; Corina Millo; Thomas S Uldrick; Karen Aleman; Millie Whatley; Kathleen M Wyvill; Deirdre O'Mahony; Vickie Marshall; Denise Whitby; Roberto Maass-Moreno; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  J Infect Dis       Date:  2015-03-31       Impact factor: 5.226

6.  Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination.

Authors:  Anders Thomassen; Anne Lerberg Nielsen; Oke Gerke; Allan Johansen; Henrik Petersen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-22       Impact factor: 9.236

Review 7.  Rational development of radiopharmaceuticals for HIV-1.

Authors:  Chuen-Yen Lau; Frank Maldarelli; William C Eckelman; Ronald D Neumann
Journal:  Nucl Med Biol       Date:  2014-01-17       Impact factor: 2.408

8.  Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry.

Authors:  Joyce C Mhlanga; Daniel Durand; Hua-Ling Tsai; Christine M Durand; Jeffrey P Leal; Hao Wang; Richard Moore; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-28       Impact factor: 9.236

Review 9.  Positron emission tomography in patients suffering from HIV-1 infection.

Authors:  Mike Sathekge; Ingeborg Goethals; Alex Maes; Christophe van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-07       Impact factor: 9.236

10.  FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables.

Authors:  Giovanni Lucignani; Eva Orunesu; Miriam Cesari; Katia Marzo; Michela Pacei; Giulia Bechi; Andrea Gori; Sabrina Gaito; Mario Clerici; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.